Established and novel imaging biomarkers for assessing response to therapy in hepatocellular carcinoma.
about
Optimal combination of antiangiogenic therapy for hepatocellular carcinomaNew approaches for precise response evaluation in hepatocellular carcinomaTreatment Response Evaluation and Follow-up in Hepatocellular CarcinomaDocetaxel-loaded lipid microbubbles combined with ultrasound-triggered microbubble destruction for targeted tumor therapy in MHCC-H cellsAssessment of response to therapy in hepatocellular carcinomaThe Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations.Hepatobiliary quiz-12 (2014).Imaging for assessment of treatment response in hepatocellular carcinoma: Current update.Antiangiogenic therapies for advanced hepatocellular carcinoma.Magnetic resonance imaging biomarkers in hepatocellular carcinoma: association with response and circulating biomarkers after sunitinib therapyCD146-targeted immunoPET and NIRF Imaging of Hepatocellular Carcinoma with a Dual-Labeled Monoclonal Antibody.Evaluation of efficacy of transcatheter arterial chemoembolization combined with computed tomography-guided radiofrequency ablation for hepatocellular carcinoma using magnetic resonance diffusion weighted imaging and computed tomography perfusion imImaging appearance of treated hepatocellular carcinomaDifferentiating malignant vertebral tumours from non-malignancies with CT spectral imaging: a preliminary study.Sudden cardiac death in a patient with advanced hepatocellular carcinoma with good response to sorafenib treatment: A case report with literature analysis.Intravoxel incoherent motion MRI for monitoring the therapeutic response of hepatocellular carcinoma to sorafenib treatment in mouse xenograft tumor models.Imaging Evaluation Following 90Y Radioembolization of Liver Tumors: What Radiologists Should Know.
P2860
Q26799458-F14F7031-2DFD-46C7-BE2F-37CFA9E87F81Q26866367-99EF9694-32A7-4266-B0F2-CF9D1456F7DFQ26992004-5507EFA2-0194-4EBC-9C85-E10338F7AFA7Q30376445-4481704C-A9BF-48A8-BF6D-5C6E55A9EB19Q33560982-C76EE80C-FB64-4FC1-A820-E9CA690FA6DAQ34826535-FEB51D84-6686-47B3-8C37-79152816C35BQ34983479-C0688101-1864-49D1-9096-A67DCF1422FDQ35568722-ACD932CD-12CE-4557-8E06-945C42D0DDC4Q36804518-612A4DF1-4534-4981-9079-2291E15E2325Q37042355-F2F18DB7-FE07-4E72-AF94-C94188FFE02EQ37202324-565A5DEC-F9D5-49ED-81A7-5C2BED7F4F9BQ37613344-C7DAE69E-0F96-4FEA-B23D-942D0FC71D99Q38136207-0558F919-6BBD-408F-A6F8-0948DB96134BQ38498731-7D928550-FAD1-406C-B6A6-EECE8050B923Q42136590-DCC11637-BB69-466F-A660-9974A5C2D155Q52891816-975826D0-CBE4-4355-BAE0-B3EEC2141353Q55283883-4389A3AE-B0E9-4333-8B33-31EDCEA6F90D
P2860
Established and novel imaging biomarkers for assessing response to therapy in hepatocellular carcinoma.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Established and novel imaging ...... y in hepatocellular carcinoma.
@en
type
label
Established and novel imaging ...... y in hepatocellular carcinoma.
@en
prefLabel
Established and novel imaging ...... y in hepatocellular carcinoma.
@en
P2093
P1476
Established and novel imaging ...... y in hepatocellular carcinoma.
@en
P2093
Andrew X Zhu
Dushyant V Sahani
P304
P356
10.1016/J.JHEP.2012.08.022
P577
2012-08-31T00:00:00Z